Home
Market Capitalization of Anthem Biosciences Ltd

Anthem Biosciences Ltd
NSE: ANTHEM
Market Cap
Key Highlights
- The Market Cap of Anthem Biosciences Ltd is ₹ 41017 crore as of 21 Jul 25 .
- The Latest Trading Price of Anthem Biosciences Ltd is ₹ 730.35 as of 21 Jul 15:30 .

Anthem Biosciences Ltd
NSE: ANTHEM
Share Price
Market Price of Anthem Biosciences Ltd
1M
1Y
3Y
5Y
Last Ten Days Market Price
Date | |
---|---|
21 Jul 2025 | 730.35 |
BlinkX Score for Anthem Biosciences Ltd
Asset Value vs Market Value of Anthem Biosciences Ltd
Market Value
₹ 0
Asset Value
₹ 0
* All values are in ₹ crores
Competitive Comparison of Market Cap
Key Valuation Metric of Anthem Biosciences Ltd
Historical P/E Ratio of Anthem Biosciences Ltd
The price-to-earnings ratio (P/E ratio) is a valuation measure calculated by dividing a company's current share price by its earnings per share. P/E Ratio Formula P/E ratio = (CMP of share/ Earning per share) Types of Price to Earning Ratio 1. Forward P/E ratio: It is calculated by simply dividing the price of a single unit of a company along with the estimated earnings of a company derived from its future earning guidance. 2. Trailing P/E ratio: It is the most common metric used by investors where past earnings of a company over a period are considered.
Historical P/E Ratio of Anthem Biosciences Ltd
Historical Revenue of Anthem Biosciences Ltd
Revenue term means the amount of money a company earns from its primary business activities such as the sales of its products & services.\r\r\n\r\r\nTypes of Revenue:\r\r\n\r\r\n1. Operating revenue: It refers to the income generated from the core business activities, which are sales of goods or services rendered.\r\r\n\r\r\n2. Non-Operating revenue: It is the income generated from secondary sources unrelated to the primary business. Examples include rents, dividends, interest, and royalty fees.\r\r\n\r\r\nFormula for Revenue:\r\r\n\r\r\nThe formula for calculating revenue is based on two goods & services:\r\r\n\r\r\nFor goods:\r\r\nRevenue = Avg unit price x Number of Units sold\r\r\n\r\r\nFor services:\r\r\nRevenue = Avg unit price x Number of Customers served.
Historical Revenue of Anthem Biosciences Ltd
Historical EBITDA of Anthem Biosciences Ltd
PBIDT stands for Profit Before Interest, Depreciation, and Taxes. It is a financial metric that measures a company's profitability before accounting for interest expenses, depreciation of assets, and taxes. Formula to calculate PBIDT: PBIDT = Net Income + Interest + Depreciation + Taxes or PBIDT = Operating Income + Depreciation + Taxes PBIDT vs EBITDA vs EBIT vs EBT: Here is a brief explanation of the differences: - PBIDT (Profit Before Interest, Depreciation, and Taxes) includes taxes in its calculation, unlike EBITDA. - EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) excludes taxes and interest, focusing on operational performance. - EBIT (Earnings Before Interest and Taxes) excludes interest and taxes, providing a measure of core operational profitability. - EBT (Earnings Before Taxes) includes all operating income but does not account for interest expenses. Conclusion: PBIDT, similar to EBITDA, is a measure of operational profitability but includes taxes in its calculation.
Historical EBITDA of Anthem Biosciences Ltd
Historical Net Profit of Anthem Biosciences Ltd
Net profit is the amount of money a company retains after accounting for all expenses, depreciation, interest, taxes, and other deductions.\r\r\n\r\r\nNet Profit formula is expressed as:\r\r\n\r\r\nNet Profit = Total Revenue - Total Expense\r\r\n\r\r\nNet Profit Margin Ratio:\r\r\n\r\r\nNet Profit Margin Ratio = Net Profit / Total Revenue
Historical Net Profit of Anthem Biosciences Ltd
Dividend Payout Over Time
About Anthem Biosciences Ltd
- Anthem Biosciences Limited was originally incorporated as 'Anthem Biosciences Private Limited', dated June 13, 2006, issued by RoC. Subsequently, Company was converted from a Private Company to a Public Company , followed by the change in name of the Company to 'Anthem Biosciences Limited' and a Certificate of Incorporation upon the conversion was issued by RoC on December 10, 2024. The Company has been set up as a Life sciences/ Biotechnology based venture specialising in the manufacture of catalytic preparation, other organic compounds such as speciality organic molecules, biologically active peptides etc., which are high-value products used in drug, agrochemical and speciality chemicals industries. The Company started operations at Unit I and set up a Custom Synthesis Plant with a capacity of 6 KL in year 2007.
Anthem Biosciences Ltd News Hub
Anthem Biosciences IPO ends with 63.86x subscription
The initial public offer of Anthem Biosciences received bids for 2,81,45,24,128 shares as against 4,
Read more
17 Jul 25
Anthem Biosciences IPO subscribed 73%
The initial public offer of Anthem Biosciences received bids for 32,113,406 shares as against 44,070
Read more
14 Jul 25
Anthem Biosciences IPO subscribed 3.28 times
The initial public offer of Anthem Biosciences received bids for 14,47,66,596 shares as against 4,40
Read more
15 Jul 25
Anthem Biosciences jumps on debut
The scrip was listed at Rs 723.10, exhibiting a premium of 26.86% to the issue price. So far, the st
Read more
21 Jul 25